Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Gliatech (GLIA) -- Ignore unavailable to you. Want to Upgrade?

To: Biotech Jim who wrote (946)	9/27/1999 5:14:00 PM
From: scaram(o)uche	Read Replies (1) \| Respond to of 2001

Jim: I'll copy your post and send it to IR at GLIA. Thanks for the pointer. Rick What is claimed: 1. An isolated nucleic acid encoding a glycine transporter comprising a sequence encoding the protein sequence of (i) SEQ ID 19 or (ii) a sequence corresponding to the protein sequence of SEQ ID 19 except that it has one or more of the following amino acid substitutions (1) Ser102 to Gly, (2) Ser124 to Phe, (3) Ile279 to Asn, (4) Arg393 to Gly, (5) Lys457 to Asn, (6) Asp463 to Asn, (7) Cys610 to Tyr, (8) Ile611 to Val, (9) Phe733 to Ser or (10) Ile735 to Val. : This application is related to the following co-pending applications: "Glycine Transporter-Transfected Cells and Uses Thereof," Ser. No. 08/655,836, filed May 31, 1996; "Pharmaceutical For Treatment Of Neurological And Neuropsychiatric Disorders," Ser. No. 08/656,063, filed May 31, 1996, now a provisional application "Pharmaceutical For Treatment of Neuropsychiatric Disorders," Ser. No. 08/655,912, filed May 31, 1996, now a provisional application and "Pharmaceutical For Treating Of Neurological and Neuropsychiatric Disorders," Ser. No. 08/655,847, filed May 31, 1996, now a provisional application